Tumour-Natural Killer and CD8+ T Cells Interaction Model with Delay

被引:2
|
作者
Awang, Nor Aziran [1 ]
Maan, Normah [1 ]
Sulain, Mohd Dasuki [2 ]
机构
[1] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Johor Baharu 81310, Malaysia
[2] Univ Sains Malaysia, Dept Sch Hlth Sci, Kota Baharu 16150, Malaysia
关键词
tumour cell; immune system; delay differential equations (DDEs); stability analysis; MATHEMATICAL-MODEL; IMMUNE-RESPONSE; CANCER; IMMUNOTHERAPY; CHEMOTHERAPY; WORLDWIDE;
D O I
10.3390/math10132193
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
The literature suggests that effective defence against tumour cells requires contributions from both Natural Killer (NK) cells and CD8(+ )T cells. NK cells are spontaneously active against infected target cells, whereas CD8(+ )T cells take some times to activate cell called as cell-specific targeting, to kill the virus. The interaction between NK cells and tumour cells has produced the other CD8(+ ) T cell, called tumour-specific CD8(+ ) T cells. We illustrate the tumour-immune interaction through mathematical modelling by considering the cell cycle. The interaction of the cells is described by a system of delay differential equations, and the delay, tau represent time taken for tumour cell reside interphase. The stability analysis and the bifurcation behaviour of the system are analysed. We established the stability of the model by analysing the characteristic equation to produce a stability region. The stability region is split into two regions, tumour decay and tumour growth. By applying the Routh-Hurwitz Criteria, the analysis of the trivial and interior equilibrium point of the model provides conditions for stability and is illustrated in the stability map. Numerical simulation is carried out to show oscillations through Hopf Bifurcation, and stability switching is found for the delay system. The result also showed that the interaction of NK cells with tumour cells could suppress tumour cells since it can increase the population of CD8(+) T cells. This concluded that the inclusion of delay and immune responses (NK-CD8(+) T cells) into consideration gives us a deep insight into the tumour growth and helps us understand how their interactions contribute to kill tumour cells.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] CD8+ regulatory T cells
    不详
    IMMUNOBIOLOGY, 2004, 209 (4-6) : 456 - 457
  • [32] CD8+ T cells in autoimmunity
    Walter, U
    Santamaria, P
    CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (06) : 624 - 631
  • [33] CD8+ T cells in tuberculosis
    Lazarevic, V
    Flynn, J
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (08) : 1116 - 1121
  • [34] CD8+ T Cells in Atherosclerosis
    Schaefer, Sarah
    Zernecke, Alma
    CELLS, 2021, 10 (01) : 1 - 16
  • [35] Changes of frequency and expression level of CD161 in CD8+ T cells and natural killer T cells in peripheral blood of patients with systemic lupus erythematosus
    Park, Yumi
    Lim, Jinsook
    Kim, Seon Young
    Kwon, Gye Cheol
    Koo, Sun Hoe
    Kim, Jimyung
    MICROBIOLOGY AND IMMUNOLOGY, 2020, 64 (07) : 532 - 539
  • [36] CD4+ and CD8+ regulatory T cells subvert tumour immunity depending on the site of tumour growth
    Jarnicki, A
    Lysaght, J
    Todryk, SM
    Mills, KHG
    IMMUNOLOGY, 2005, 116 : 33 - 33
  • [37] Murine CD8+ Invariant Natural Killer T Cells are Negatively Selected by CD1d Expressed on Thymic Epithelial Cells and Dendritic Cells
    Oh, Sejin
    Lee, Hyunji
    Shin, Jung Hoon
    Hong, Changwan
    Park, Se-Ho
    IMMUNOLOGICAL INVESTIGATIONS, 2018, 47 (01) : 89 - 100
  • [38] Degradation of hyaluronan from the tumor extracellular matrix increases infiltration of CD8+ T cells and natural killer cells in an orthotopic pancreatic tumor model.
    Lee, Jisook
    Kimbler, Trevor
    Thompson, Curtis
    Thompson, Benjamin J.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 61 - 61
  • [39] Comparison of CD8+ and CD8neg human natural killer cell subsets
    Abdalla, I. I.
    IMMUNOLOGY, 2010, 131 : 84 - 84
  • [40] PD-1 Expression on Natural Killer Cells and CD8+ T Cells During Chronic HIV-1 Infection
    Norris, Sonia
    Coleman, Adam
    Kuri-Cervantes, Leticia
    Bower, Mark
    Nelson, Mark
    Goodier, Martin R.
    VIRAL IMMUNOLOGY, 2012, 25 (04) : 329 - 332